Last reviewed · How we verify

Imipraminoxide (imipramine oxide)

unknown active

Imipraminoxide (generic name: imipramine oxide) is a imipramine oxide drug. It is currently in unknown development.

Imipraminoxide is thought to work by inhibiting the reuptake of certain neurotransmitters in the brain.

Imipraminoxide, also known as imipramine oxide, is a small molecule drug in the imipramine oxide class. Its mechanism of action is not well-documented, and it is not FDA-approved for any indications. The half-life of imipraminoxide is approximately 1.8 hours. Due to the lack of information on its commercial status and approved indications, it is difficult to provide a comprehensive summary. Further research is needed to understand the properties and potential uses of imipraminoxide.

At a glance

Generic nameimipramine oxide
Drug classimipramine oxide
Therapeutic areaNeuroscience
Phaseunknown

Mechanism of action

Imagine your brain is a city with many different streets and buildings. Neurotransmitters are like messengers that travel along these streets, carrying information from one building to another. Imipraminoxide helps to keep these messengers in the streets for longer, allowing them to have a greater impact on the city's functioning.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Imipraminoxide

What is Imipraminoxide?

Imipraminoxide (imipramine oxide) is a imipramine oxide drug.

How does Imipraminoxide work?

Imipraminoxide is thought to work by inhibiting the reuptake of certain neurotransmitters in the brain.

What is the generic name of Imipraminoxide?

imipramine oxide is the generic (nonproprietary) name of Imipraminoxide.

What drug class is Imipraminoxide in?

Imipraminoxide belongs to the imipramine oxide class. See all imipramine oxide drugs at /class/imipramine-oxide.

What development phase is Imipraminoxide in?

Imipraminoxide is in unknown.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing